European Vascular Biology Organisation
We are proud to announce the formation of the European Vascular Biology Organisation. The decision to found EVBP was taken unanimously by committee members of the European Vascular Biology Association and the European Vascular Genomics Network during the Third European Meeting on Vascular Biology and Medicine in Hamburg, Germany on October 2nd 2005.
As a first step, the interim Council of EVBO has called for Founder Members who are established vascular biologists permanently based in a European laboratory. To support their status as established vascular biologists, applicant musts have 3 first or senior author publications in relevant journals with an impact factor greater than 3 in the past 5 years.

The EVBO council has been elected, follow the link to learn about the members

European Society of Cardiology
The goals of the ESC were clearly defined in the original statutes: "To foster the development of cardiology, to further scientific exchanges, to encourage personal contacts and to establish standards of training for cardiologists and those who work in the field of cardiovascular disease". The European Society of Cardiology has now broadened its goals and is "dedicated to improving the quality of life of the European population by reducing the impact of cardiovascular disease". These goals have clearly been achieved as the Society now includes 47 National Societies, 23 Working Groups, 3 Associations, a Science Council and over 37.000 members. The Annual Congress of the ESC is the largest medical forum in Europe, which presents the latest developments in experimental and clinical cardiology.

http://www.escardio.org

European Atherosclerosis Society
The European Atherosclerosis Society, founded in 1964, is devoted to advancing knowledge
of the causes, natural history, treatment and prevention of Atherosclerosis. Currently composed of about 400 senior and junior researchers in basic as well as clinical science, membership is open to scientists and physicians working in Europe and in neighboring countries. One major activity of the European Atherosclerosis Society is the organization of a large annual congress as well as several smaller scientific workshops. Another is the development of guidelines for the treatment and especially the prevention of atherosclerotic disease based on sound scientific evidence.

e-mail: eas.soc@telia.com
Contact person: Irene Jack Executive Director EAS (for contact primarily with medical and scientific professionals)
Address: Altonagatan 7, SE 21138, Malmö, Sweden
Tel: +46 40 240 750
Fax: +46 40 240 751

European Society for Microcirculation
The European Society for Microcirculation was formed over 20 years ago and now has
approximately 200 members. Its aim is to advance integrative understanding of physiology and pathophysiology of terminal vascular beds to support classical microcirculation as well as vascular biology to use basic as well as clinical studies. Its biannual conferences are attended by about 800 scientists from all over the world. Specific goals of the Society are to encourage and help young scientists to join this exciting and important field through Travel Awards to attend its meetings, as well as Career Development Awards to allow them to visit other institutions and learn new techniques. In addition, the Society encourages the development of microvascular science in other European countries and in particular the former Eastern bloc. Since 1980, the Society has its own journal, the Journal of Vascular Research, an international publication of growing impact, through which the world wide scientific community is informed of the Society's endeavours.

http://www.medizin.fu-berlin.de/esm

European Heart Network
The European Heart Network (EHN) is a Brussels-based alliance of heart foundations and
likeminded non-governmental organisations throughout Europe. EHN has 30 member
organisations in 26 countries. The European Heart Network plays a leading role in the
prevention and reduction of cardiovascular disease through advocacy, networking and
education so that it is no longer a major cause of premature death and disability throughout Europe. Through its membership of the World Heart Federation, EHN is also active in the creation of a wider international heart network whose aim is to advance the cause of cardiovascular health promotion world-wide.

http://www.ehnheart.org

World Heart Federation
The World Heart Federation helps people achieve a longer and better life through prevention and control of heart disease and stroke, with a focus on low and middle income countries. The World Heart Federation is a close partner of the World Health Organization's division for Non-communicable Diseases and it is the only NGO recognized by the World Health Orgazination as partner in heart disease treatment and control. Joint projects are continuously being carried out. An agreement between UNESCO, WHO and the World Heart Federation instigates cooperation in the prevention of rheumatic fever/rheumatic heart disease, Chagas' disease and risk factors in school age children in developing countries.

http://www.worldheart.org

Cardiology Online - International Academy of Cardiology
The International Academy of Cardiology is dedicated to the advancement of global research in cardiovascular medicine through the support of scientific meetings and publications. Thought its website is possible to reach a comprehensive list of congress, meetings, news, reviews and publication on heart disease.

e-mail: klimedco@ucla.edu
Contact person: Asher Kimchi, M.D., Chairman, International Academy of Cardiology
Address: PO Box 17659, Beverly Hills, CA 90209, USA
Tel: 1-310-657-8777
Fax: 1-310-275-8922

Cardiovascular GO Annotation Initiative

The Cardiovascular Gene Ontology (GO) Annotation Initiative was launched on the 1st November 2007 as a collaboration between University College London and the European Bioinformatics Institute.  This initiative is funded by the British Heart Foundation and aims to work with the cardiovascular community to prioritise the annotation of genes associated with the cardiovascular system and ensure that high quality gene annotations are available for the analysis of high-throughput data.

http://www.ucl.ac.uk/medicine/cardiovascular-genetics/geneontology.html